Skip to content

Author

G. Paul

We have 2 of 69 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Initiating levodopa pump therapy: a qualitative study of patient and caregiver perspectives

It is highlighted that although symptom control improved, both PwPD and FC continued to face practical and emotional challenges, and supporting their adaptation process requires coordinated, person-centred preparation, guidance and follow-up from multidisciplinary, specialized PD teams.

M. Scharfenort, Anette Nobrell, Michela Garon et al. · 0 citations
Open access Jul 2026

Human embryonic stem cell-derived dopaminergic cells for Parkinson’s disease: a phase 1/2 open-label trial

A phase 1/2 trial of an off-the-shelf stem cell-derived dopaminergic progenitor therapy demonstrated a favorable 12-month safety profile, with no graft-related adverse events, dyskinesias or tumor formation, although risks were associated with the immunosuppression regimen.

G. Paul, H. Bjartmarz, A. Kirkeby et al. · 2 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.